Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

The latest in immuno research, from the discovery & development of cell & antibody therapies through to omics-based approaches and clinical case studies

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Translational & Preclinical Development

The Future of CAR T for Solid Tumours: Antigen Discovery, Persistence, and Fitness

CAR T, the rockstar therapy of immuno-oncology, finds its next big challenge in translating research for use in solid tumours.
Read More
Translational & Preclinical Development

Developing Novel Theranostic Approaches for the Development of Oncolytic Viruses

Single-cell, real-time analysis of oncolytic viruses’ efficacy, and replication in living cancer cells.
Read More
Autoimmunity & Immunology

Treating Autoimmune Diseases: Past, Present, and Future

Bringing together the experts to discuss the timeline of autoimmune disease therapeutics.
Read More
Tumour Microenvironment

Tackling Solid Tumours in Immuno-Oncology

What’s next for CAR T cell therapy? What’s the best way to develop combination therapies for multi-modal efficacy?
Read More
Therapeutic Modalities

Targeting Solid Tumours With TCR Guided NK Cells

Video Interview | Namir Hassan, CEO at Zelluna Immunotherapy
Read More
Translational & Preclinical Development

Better IO Clinical Trials with ImmunoPET Imaging

Ian A Wilson of ImaginAb delivers the presentation ‘The Value of In Vivo Imaging on the Clinical Development of IO Drugs’ at Oxford Global’s discussion group.
Read More
Translational & Preclinical Development

Search and Destroy: Engineering T-Cells to Find and Kill Cancer

Oxford Global’s Immuno Week showcased new ways of reprogramming the immune system to treat malignancy with TCR-T.
Read More
Biomarkers in Immuno-Oncology

Three Leading Perspectives on Biomarker Diagnostic Discovery in Immuno-oncology

Early and effective treatment of cancers could mean the difference between life and death. Therefore, companion diagnostics and biomarker discovery could be considered one of the most important avenues to explore in immuno-oncology.
Read More
Autoimmunity & Immunology

Insights in Autoimmunity and Immunotherapy

Experts discuss elusively successful therapies and the rising costs that come with new technologies.
Read More
Autoimmunity & Immunology

Re-Educating the Immune System: a ‘Brave New World’ in Immunology

RevoloBio’s autoimmunity drug, ‘1805, breaks with the mould in its revolutionary approach. With success in a Phase II clinical trial, scientists wonder what’s around the corner for the field.
Read More
Translational & Preclinical Development

Multi-Specific Protein Modalities For Solid Tumours

An interview with Rajika Perera, Chief Executive Officer, Poseidon Laboratory
Read More
Therapeutic Modalities

Are Genomic Technologies the Key to Unlock Precision Immunotherapies?

The power of the genome has enormous implications for immunotherapy
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things immuno